Questions discussed in this category
At the time of initial diagnosis, there was no clear CNS involvement. When it became clinically apparent disease was refractory to EPOCH, there was CS...
Would you offer consolidative brain SRS, SRS + consolidative RT to the primary (e.g. lung), consolidative RT to the primary alone?
Would the rate of growth, number of nodes involved, size of nodes, ENE etc. affect your decision?
What volume and dose would you recommend?
Aside from symptomatic disease, is there a certain growth cutoff or other criteria that would be a trigger for treatment?
201682102318979172121665412794121071107998887851
Papers discussed in this category
Multiple sclerosis (Houndmills, Basingstoke, England), 2014-01
Ann. Neurol., 2018 Feb 15
Int. J. Radiat. Oncol. Biol. Phys., 2011 Jun 15
Cancer, 2004-12-01
Blood advances, 2023 Sep 26